Bile duct involvement in autoimmune pancreatitis: classification and treatment - HAL Accéder directement au contenu
Article dans une revue Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology Année : 2008

Bile duct involvement in autoimmune pancreatitis: classification and treatment

R. Gincul
  • Fonction : Auteur
B. Pujol
  • Fonction : Auteur
J. Dumortier
J. Y. Scoazec
  • Fonction : Auteur
V. Hervieu
  • Fonction : Auteur
A. Crombe-Ternamian
  • Fonction : Auteur
B. Napoléon
  • Fonction : Auteur
T. Ponchon
  • Fonction : Auteur

Résumé

Autoimmune pancreatitis is a rare disease characterized by inflammation of the pancreatic parenchyma, irregular narrowing of the pancreatic duct, periductal lymphoplasmacytic infiltration and fibrosis at histological examination, the presence of autoantibodies and hypergammaglobulinemia, as well as the possible association of cholangitis and other autoimmune diseases. There is a favorable response to steroid therapy. We report the case of a patient with autoimmune pancreatitis with bile duct involvement and peripheral eosinophilia, requiring long-term immunosuppressant treatment. The diagnosis of a diffuse form of AIP was made without direct histological evidence and based on indirect imaging, clinical and laboratory findings in an autoimmune context. The histological and imaging studies of bile duct involvement and the favourable response to steroids were additional arguments.
Loading...
Fichier non déposé

Dates et versions

hal-00443254, version 1 (29-12-2009)

Identifiants

  • HAL Id : hal-00443254 , version 1

Citer

R. Gincul, B. Pujol, J. Dumortier, J. Y. Scoazec, V. Hervieu, et al.. Bile duct involvement in autoimmune pancreatitis: classification and treatment. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2008, 32 (11), pp.914--921. ⟨hal-00443254⟩
57 Consultations
0 Téléchargements
Dernière date de mise à jour le 25/06/2024
comment ces indicateurs sont-ils produits

Partager

Gmail Facebook Twitter LinkedIn Plus